Eupatilin attenuates the inflammatory response induced by intracerebral hemorrhage through the TLR4/MyD88 pathway.

CONCLUSION: Eupatilin has a therapeutic effect on inflammation caused by ICH. The underlying mechanism may be related to TLR4/MyD88, which brings new hope for clinical patients to improve symptoms and prognosis.
PMID: 31476693 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - August 29, 2019 Category: Allergy & Immunology Authors: Fei X, Chen C, Kai S, Fu X, Man W, Ding B, Wang C, Xu R Tags: Int Immunopharmacol Source Type: research